Therefore, elucidating the molecular mechanisms underlying ILF2 ability to induce cancer cell proliferation and whether this is mediated by ILF2–ILF3 interactions in HCC pathogenesis, requires further study. The gene discussed is ILF3; the disease is hepatocellular carcinoma.